Tattoo ink reaches the lymph nodes. Does it raise lymphoma risk?

Ink on the move

Tattooing pushes pigment into the dermis. The immune system treats the particles as foreign material. Immune cells engulf some of them and carry them through lymphatic vessels to the nearest lymph nodes. Lymph nodes near a tattoo can end up visibly stained the color of the ink¹.

In 2017, a team led by researchers at the German Federal Institute for Risk Assessment used synchrotron X-ray imaging on tissue from deceased donors. They confirmed that pigments, including titanium dioxide, the white base used in many colored inks, reach the lymph nodes. Smaller organic pigment particles traveled there more readily. The team also saw protein and lipid changes in the tissue around the deposits¹.

A 2025 mouse study in PNAS followed what happens next. Macrophages, the immune cells that clean up debris, captured the ink in the lymph nodes and then died. Inflammation in the nodes was still clear two months after tattooing. Ink at a vaccine injection site also changed vaccine responses: antibody responses fell for an mRNA COVID-19 vaccine and rose for an inactivated influenza vaccine².

Long-lasting inflammation is a known contributor to some cancers, which is why these findings matter. But the mouse work has critics. A 2026 letter in the same journal argued that injecting vaccines into tattooed mouse footpads is too far from clinical reality to say much about people⁶.

The ink itself is another concern. Black ink usually contains carbon black, which the International Agency for Research on Cancer classes as possibly carcinogenic to humans. Making carbon black can also produce polycyclic aromatic hydrocarbons (PAHs) as byproducts, and some of those are known carcinogens⁴.

What the population studies found

Sweden, 2024

Researchers at Lund University found everyone in Sweden aged 20–60 who was diagnosed with lymphoma between 2007 and 2017. They compared these patients with randomly chosen people of the same age and sex. Participants reported their tattoo history in a 2021 questionnaire, which about half of those invited completed³.

Tattooed people had an estimated 21% higher rate of lymphoma. That is the figure most news coverage reported. The confidence interval, however, ran from 0.99 to 1.48, so the overall result fell just short of statistical significance. The clearest signal was in people who got their first tattoo less than two years before diagnosis (risk ratio 1.81, 95% CI 1.03–3.20). The authors found no rise in risk with larger tattooed areas, which is not what you would expect if the ink were the cause³.

Denmark, 2025

A team at the University of Southern Denmark used the Danish Twin Tattoo Cohort. Twins share genes and much of their upbringing, so comparing them helps rule out some confounding factors. Tattoos larger than the palm of a hand were linked to a 2.73 times higher hazard of lymphoma and a 2.37 times higher hazard of skin cancer⁴.

The numbers were small, though. The study included 316 twins in its case-control arm, and only 14 twin pairs could be used in its most tightly matched comparison, which looked at skin cancer. That comparison was not statistically significant, and the wide intervals reflect how few cases were involved⁴.

The 2026 synthesis

In June 2026, a team led by Gabriel Tudella published a systematic review and meta-analysis in Clinical and Translational Oncology. They pooled seven observational studies covering 140,841 people⁵.

• Blood cancers overall: no significant association (OR 1.02, 95% CI 0.78–1.32).
• Lymphoma subtypes: no significant association for non-Hodgkin, Hodgkin, diffuse large B-cell, T-cell or follicular lymphoma.
• Skin cancer: no association (OR 0.92, 95% CI 0.83–1.04).
• The caveat: dropping one influential study made the blood-cancer link significant (OR 1.20, 95% CI 1.05–1.39).

The authors rated the certainty of the evidence as low to moderate. They called for cautious interpretation and prospective studies, meaning studies that record tattoo exposure before anyone gets sick⁵.

Why the evidence is hard to read

• Confounding. People with tattoos may differ from people without them in smoking, alcohol, sun exposure, work exposures and other habits. Studies adjust for what they can measure, but not for everything.
• Recall and response bias. The Swedish and Danish studies asked about tattoos years after diagnosis. Cancer patients and healthy controls may answer surveys at different rates, or remember things differently.
• Mixed dose signals. Denmark saw higher risk with larger tattoos. Sweden did not. A real causal effect would usually show a consistent dose–response pattern.
• Ink varies. Pigments, impurities and manufacturers vary widely by color, country and decade. Studies so far cannot say which inks, if any, matter.
• Relative, not absolute. Even if the 20% figure holds up, it is a relative increase in an uncommon cancer. A 1.2 ratio does not mean a 20% chance of getting lymphoma.

What it means for people with tattoos

The current evidence does not show that tattoos cause lymphoma, and it does not rule out a modest risk. The best-documented harms of tattooing are still infections, from unsterile equipment or contaminated ink, and occasional allergic reactions. The US Food and Drug Administration notes that no color additive is approved for injection into the skin⁷.

For now, the practical advice has not changed: choose a licensed studio that follows hygiene standards, ask what inks it uses, and report persistent reactions or swollen lymph nodes to a clinician. If the coming prospective studies find a consistent link, researchers will need to work out which pigments are responsible. That would point to safer inks, not just fewer tattoos.